Management of metastatic renal cell carcinoma – mini review

Anubha Bharthuar, Himanshu Pandey, Swapan Sood

Abstract


The management of metastatic renal cell carcinoma (mRCC) has evolved considerably in the last decade. A number of different systemic molecular targeted agents that have been recently approved have improved the survival of patients with mRCC. This mini-review focuses on the implementation of multi-modality therapy in the management of mRCC and the approved indications of the various available novel agents. These novel agents have expanded our armamentarium and improved clinical outcomes of this challenging disease that has considerable biological heterogeneity and clinical variability.  


Keywords


Metastatic renal cell carcinoma; Prognostic models; Targeted therapy

Full Text:

HTML PDF


DOI: http://dx.doi.org/10.15586/jkcvhl.2015.28

Article Metrics

Metrics Loading ...




Copyright (c) 2015 Anubha Bharthuar, Himanshu Pandey, Swapan Sood

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.